HDFC Life Insurance Q4 FY26 Results: PAT Rises 4.65% to ₹497 Crore, AUM at ₹3.75 Lakh Crore, Dividend ₹2.10/Share And ₹1,000 Cr Preferential Issue Approved

HDFC Life Insurance Company declared its Q4 FY26 results on April 16, 2026, posting a standalone PAT of ₹495.65 crore — up 4.01% year-on-year — and a consolidated PAT of ₹497.49 crore, up 4.65% from ₹476.54 crore in Q4 FY25. The full-year FY26 PAT grew 6% to ₹1,910 crore. Net premium income for Q4 surged 9.04% year-on-year to ₹25,998.42 crore. AUM including subsidiary HDFC Pension Fund Management reached ₹3.75 lakh crore — up 12% year-on-year.

The most significant announcement alongside the results: the board approved raising up to ₹1,000 crore via a preferential issue of 1,45,23,906 equity shares at ₹688.52 per share to promoter HDFC Bank — a move specifically aimed at augmenting the company’s solvency position. The board also recommended a final dividend of ₹2.10 per equity share for FY26, with record date June 19, 2026, and payment by July 20, 2026.

CEO Vibha Padalkar stated that HDFC Life maintained its position among the top three private insurers, with retail protection growing 43% and agency channel outperforming industry. Get live results alerts and research on Univest.

HDFC Life Insurance Q4 FY26 Financial Results

Source: HDFC Life BSE/NSE regulatory filings, audited financial statements, April 16, 2026.

What the Numbers Mean: 3 Key Takeaways

First, the 4.65% PAT growth is modest but clean — no large exceptional items distort the Q4 print. The investment income line swung to a net loss of ₹6,487.58 crore in Q4 FY26 versus a small profit of ₹18.99 crore in Q4 FY25, reflecting mark-to-market losses on equity investments in a volatile market. This significantly impacted the headline PAT. Stripping this out, the underlying operating performance — driven by strong premium growth and controlled expenses — is healthier than the headline 4.65% growth suggests.

Second, the ₹1,000 crore preferential issue to HDFC Bank at ₹688.52 per share is a critical strategic move. It strengthens the solvency ratio (which stood at 180% in 9M FY26), provides capital headroom for the Bima Trinity initiative and protection portfolio growth. Importantly, it deepens the parent-subsidiary relationship with HDFC Bank’s distribution network — a competitive moat for insurance distribution.

Third, VNB grew 7% year-on-year for the full year. Excluding the GST impact and surrender regulation changes, management indicated underlying VNB growth would have been higher. The GST headwind from FY26 regulatory changes has been partially but not fully neutralised by year-end, and management expects this to clear in FY27.

Screen HDFC Life historical financials on the Univest Screener.

Analyst Ratings

Conclusion

HDFC Life’s Q4 FY26 numbers are steady rather than spectacular. The 4.65% PAT growth masks a stronger operational performance that was dragged down by investment mark-to-market losses in a volatile equity market. The preferential issue to HDFC Bank strengthens the franchise for long-term growth. With retail protection growing at 43%, the highest-margin segment is gaining traction. FY27 will be the year markets assess whether the GST headwind has truly cleared and whether VNB margin expansion to 27–29% is sustainable.

For more Q4 FY26 analysis, visit Univest Blogs.

Frequently Asked Questions

1. What was HDFC Life’s Q4 FY26 PAT?

HDFC Life reported consolidated Q4 FY26 PAT of ₹497.49 crore — up 4.65% year-on-year from ₹476.54 crore in Q4 FY25. Standalone Q4 PAT was ₹495.65 crore. Full-year FY26 PAT grew 6% to ₹1,910 crore.

2. What dividend did HDFC Life declare for FY26?

HDFC Life’s board recommended a final dividend of ₹2.10 per equity share (face value ₹10) for FY26. Record date is June 19, 2026; payment on or after July 20, 2026, subject to AGM shareholder approval.

3. What is the HDFC Life preferential issue?

HDFC Life’s board approved issuing 1,45,23,906 equity shares at ₹688.52 per share to its promoter HDFC Bank, raising up to ₹1,000 crore. The purpose is to augment the company’s solvency position and support growth. This requires shareholder and regulatory approvals.

4. What is HDFC Life’s AUM?

HDFC Life’s AUM — including HDFC Pension Fund Management — reached ₹3.75 lakh crore for FY26, growing approximately 12% year-on-year.

5. What was HDFC Life’s VNB growth in FY26?

HDFC Life’s Value of New Business (VNB) grew 7% year-on-year for FY26. Excluding the impact of GST regulation changes and the new surrender value regulations, adjusted VNB growth was higher. The 9M FY26 VNB margin was 24.4%, expected to recover toward 27–29% in FY27.

6. Why did HDFC Life’s investment income turn negative in Q4?

Net investment income swung to a loss of ₹6,487.58 crore in Q4 FY26 versus a ₹18.99 crore gain in Q4 FY25, driven by mark-to-market losses on equity investments in a volatile market quarter. This was a key drag on Q4 PAT and does not reflect the underlying operating business performance.

7. When do TCS announce Q4 results?

TCS declared Q4 FY26 results on April 9, 2026. HDFC Bank reports on April 18.

8. Is HDFC Life a good investment after Q4 FY26 results?

HDFC Life’s long-term structural story — India’s underpenetrated life insurance market, young demographics, rising protection awareness — remains intact. Near-term, the GST headwind normalization and VNB margin trajectory are the key variables. The ₹1,000 crore preferential issue strengthens solvency. At current prices (~₹631), the stock trades at approximately 2.1x FY26 embedded value. Consult a SEBI-registered financial advisor before investing.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data is sourced from publicly available NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Motisons Jewellers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Motilal Oswal Financial Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Moschip Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morepen Laboratories Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morarjee Textiles Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook